SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-12-000216
Filing Date
2012-02-14
Accepted
2012-02-13 18:27:57
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 VISTAGEN 10-Q DEC 31 2011 vistagen10qdec312011.htm 10-Q 1122197
2 ex31-1.htm EX-31.1 9481
3 ex31-2.htm EX-31.2 9456
4 ex32.htm EX-32 5672
  Complete submission text file 0001415889-12-000216.txt   4752143

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY PRESENTATION LINKBASE vsta-20111231_pre.xml EX-101.PRE 121767
6 XBRL TAXONOMY LABEL LINKBASE vsta-20111231_lab.xml EX-101.LAB 180751
7 XBRL TAXONOMY DEFINITION LINKBASE vsta-20111231_def.xml EX-101.DEF 113607
8 XBRL TAXONOMY CALCULATION LINKBASE vsta-20111231_cal.xml EX-101.CAL 53287
9 XBRL INSTANCE DOCUMENT vsta-20111231.xml EX-101.INS 821773
10 XBRL TAXONOMY EXTENSION SCHEMA vsta-20111231.xsd EX-101.SCH 20859
Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54014 | Film No.: 12601087
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences